Status:
COMPLETED
Coenzyme Q10 in Relation of the Lipid Peroxidation, Antioxidant Enzyme Activities in Coronary Artery Disease Patients
Lead Sponsor:
Taichung Veterans General Hospital
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
Coenzyme Q10 (Ubiquinone) is recognized as an endogenous fat-soluble antioxidant in the mitochondrial membrane and considered as a preventive factor for coronary artery disease (CAD). However, the rel...
Eligibility Criteria
Inclusion
- CAD patients is identified by cardiac catheterization as having at least 50% stenosis of one major coronary artery
Exclusion
- age \< 18 years old
- pregnancy women
- taking lowering lipid drug (Statin)
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT01163500
Start Date
July 1 2008
End Date
March 1 2009
Last Update
October 14 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taichung Verterans General Hospital
Taichung, Taiwan, 40705